FDA Investigator Brandon L Mariner

Brandon L Mariner has inspections in 8 countries as of 03 Nov 2023. Brandon L Mariner has collaborated with a combinined 5288 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
176
Last Inspection Date:
03 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Poland, France, Philippines, Australia, Japan, Germany, Canada
Co-Investigator(s):
Adams, Akbar J Zaidi, Alanna Lmussawwir Bias, Amanda B Athey, Amanda B Vega, Amanda L Evanco, Amber G Chung, Amy A Johnson, Amy C Amaro, Ana P Barido, Andrea D Swingle, Andrea Lwilliams Jones, Andrew J Garufi, Andrew J Howard, Angela E Glenn, Annette Melendez, Anthony J Grace, Arduino Frankovic, Arindam Dasgupta, PhD, Armando P Zamora, Ashley M Whitehurst, Atul J Agrawal, Austin B Appler, Babatunde D Babalola, Barbara A Burke, Barbara A Crowl, Barbara A Gullick, Barbara A Rusin, Barbara D Wright, Barbara J Holladay, Bei Yu, Brandy D Brown, Brentley S Collins, Brian M Palermo, Brian S Keefer, Brooke K Higgins, Bruce E Kummer, Burnell M Henry, Camilla S Smith, Candice C Mandera, Candice C Mandero, Candice J Cortes, Carl E Lovrich, Carol A Robles, Carol F Robinson, Carol Mrivera Lopez, PhD, Carol Rivera Lopez, PhD, Carrie L Doupnik, Charles A Snipes, PhD, Charles D Boison, Charles E Idjagboro, Charles M Kerns, BLT DO, Charles N Dupont, Charles R Bonapace, PhD, Cherlita A Honeycutt, Christian Parra, Christine A Harman, PhD, Christine W Twohy, Cody D Rickman, Cordelia J Brammer, Courtney N Long, Cynthia A Harris, MD, RN, Cynthia L Rakestraw, Daniel J Mechenbier, Daniel R Tammariello, Danielle M Maddox, David K Glasgow, David L Chon, David P Rice, Dawn C Olenjack, Deborah J Parris, Debra Boyd Seale, Dennis R Hock, Devon Jenkins, Dianne H Milazzo, Donna D Gallien, MPH, Dr. Abhijit Raha, PhD, Dr. Gopa Biswas, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Dung N Tran, Edette J Newby, Edward A Brunt, Edward D Mcdonald, Edward P Potter, Elise A Murphy, Elizabeth B Griffin, Elvin R Smith, Elvis D Morton, Emmanuel A Dimaano, Jr, Emmanuel Adu Gyamfi, Erica L Nicoll, Erika M Wilkerson, Erin L Mcfiren, Erin M Mcdowell, Evelyn Taha, Gail L Katz, Gale L Glinecki, Gamal A Norton, Gerald D Bromley, Jr, Gerald Mierle, Gifford Whitehurst, Jr, Gladys B Casper, Gopa Bisivas, Heath R Harley, Hector J Colon Torres, Helen B Ricalde, Helen R Bester, Henry E Sanchez, Holly S Simms, Huixia Zhang, Ifueko Osemwota, Irina Gaberman, Jackie O'shaughnessy, Jacqueline A O'shanghnessy, PhD, Jacqueline A O'shaughnessy, PhD, Jacqueline Johnson, Jacqueline N O'shaughnessy, James M Odonnell, James M Simpson, James T Mccoy, James W Leonette, Jamie D Swann, Janae D Price, Janet B Gray, Jaqueline A O'shaughnessy, Jean M Mulinde, MD, Jeanne D Shaffer, Jennifer L Jager, Jennifer L Sheehan, Jesse P Hardin, Jessica D Nanini, Jessica D Weber, Jill M Sooter, Jo Annc Declement, Joey C West, John A Kadavil, PhD, John Dan, Jonathan W Chapman, Joseph W Matthews, Joyce A Rockwell, Jude C Dikes, Judith A Jones, Judy Ellen Ciaraldi, Justin A Hefferman, Justin C Fuller, Justin H Price, Jyoti B Patel, PhD, Ka L Wong, Karen A Spencer, Karen M Bryerton, Karen M Cooper, Kellie L Westerbuhr, Kelly Dragon, Kenneth L Smalls, Kimberly A Dux, Kimberly Cdelk Brooks, King, Kip J Hanks, Krista N Flores, Kwong P Lee, La Tasha M Gunter, Lakisha M Williams, Laureen F Kononen, Lauren A Crivellone, Laurie A Haxel, Laurie P Norwood, Laurissa S Flowers, LCDR Anastasia Mpiliafas Brown, LCDR Cornelius Brown, III, LCDR Wilfred A Darang, Lee Hong Pai Scherf, Leena Thomas, Leigh Anne Myers, Lesley Maep Lutao, Leslie W Gilbert, Lilia L Bi, Linda S Mattingly, Lisa B Orr, Loretta Nemchik, Lori S Lawless, LT John M Mastalski, LT Melanie M Mayor, USPHS, LTJG Bradley E Benasutti, Lynette P Salisbury, Marc A Jackson, Jr, Marcelo O Mangalindan, Jr, Margaret Torres Vazquez, Marilyn M White, Marion W Nadeau, Martin K Yau, PhD, Mary R Kirker, Mary T Carden, Mathew R Manen, Matthew B Casale, Matthew J Gretkierewicz, Matthew R Mcnew, Melissa D Kalik, Meredith L Sheridan, Merideth K Rose, Miaja Umaedi, Michael F Skelly, PhD, Michelle D Gutierrez, Mildred L Mccray, Mindy M Chou, Mizanne E Lewis, Monique Rac Lester, Myra L Gemmill, Myra L Reed, Nancy L Meade, Nancy L Neiger, Nancy L Rose, Natasha A Dezinna, Natasha A Harry, Nathaniel R Esaw, Nebil A Oumer, Nerizza B Guerin, Nicholas M Smith, Nicholas P Schaub, Nichole J Chamberlain, Nisha C Patel, Normica G Facey, Osama M Hamoud, Ou Ma, Oumou Barry, Patricia A Morrow, Patricia E Weddington, Patrick C Klotzbuecher, Paul M Chefor, Paula J Bretz, Peter Abel, Prabhu P Raju, Richard J Bashay, Robert P Neligan, Roberta W Cunningham, Robin R Waller, Ronald Ifraimov, Sam H Haidar, PhD, Samuel H Chan, PharmD, Sandra P White, Sarah A Meehan, Sarah A Wangseng, Sarah Forney, Satheesh Thomas, Schultz, Sean R Moynihan, MPH, Sean Y Kassim, PhD, Shavon L Square, Sherry I Seerist, Sherry L Secrist, BLT DO, Shusheen A Alexander, Simone E Pitts, Srinivas R Chennamaneni, PhD, Stacey A Priest, Stardust W Mazzariello, State Agency, Stephanie L Shapley, Stephanie Mangigian, MS/OSH, RN, Stephanie T Durso, Stephen R King, Steven P Donald, Susan J Essenmacher, Tamal K Chakraborti, PhD, Tamara N Champion, Tamika E Allen, RN, Tania E Vizcaino, Tania K Mercado, Thomas N Adjabeng, Thomas R Withers, Tiki J Dixon, Timothy J Schmidt, Traci M Armand, Travis M Beard, Travis R Hunt, Upendra Paudel, Uttaniti Limchumroon (Tom), Valeria A Moore, Vivian Garcia, Wanda B Coats, Wanda Y Fields, Wanda Y Honeyblue, William A Warnick, William D Bassett, Jr, William D Murray, William H Linkroum, Xikui Chen (nmi), PhD, Yangmin Ning, Yih Chain Huang, PhD, Young M Yoon

Brandon L Mariner's Documents

Publish Date Document Type Title
September, 2022 FDA 483 Response Akan Biosciences LLC - Form 483R, 2022-09-30
August, 2015 EIR PPD Development, L.P. - EIR, 2015-08-21
July, 2015 EIR BASI Gaithersburg, LLC - EIR, 2015-07-29
November, 2019 FDA 483 Catalent Maryland, Inc. - Form 483, 2019-11-04
September, 2019 FDA 483 Medstar Georgetown University Hospital - Form 483, 2019-09-10
November, 2019 FDA 483 Response Catalent Maryland, Inc. - Form 483R, 2019-11-25
September, 2022 FDA 483 Akan Biosciences LLC - Form 483, 2022-09-30
August, 2019 FDA 483 ITxM Clinical Services - Form 483, 2019-08-01
October, 2022 FDA 483 IVF/ART Laboratories/JHH at Green Spring Station - Form 483, 2022-10-24
September, 2016 FDA 483 Catherine Chiron - Form 483, 2016-09-09
July, 2015 EIR Natarajan Ravendhran, M.D. - EIR, 2015-07-17
March, 2014 EIR PAREXEL INTERNATIONAL CORPORATION - EIR, 2014-03-10
September, 2019 FDA 483 Rowny Systems, Inc. - Form 483, 2019-09-17
April, 2016 EIR Osiris Therapeutics Inc - EIR, 2016-04-07
January, 2014 EIR Advarra IRB - EIR, 2014-01-07
April, 2014 EIR Pharmasite Research, Inc. - EIR, 2014-04-10
July, 2015 FDA 483 Natarajan Ravendhran, M.D. - Form 483, 2015-07-17
November, 2019 EIR Catalent Maryland, Inc. - EIR, 2019-11-04
April, 2017 EIR Fisher BioServices - EIR, 2017-04-21
November, 2017 FDA 483 Sense Technology Inc - Form 483, 2017-11-06
June, 2022 FDA 483 Rowny Systems, Inc. - Form 483, 2022-06-17
August, 2019 FDA 483 ITxM Clinical Services - Form 483, 2019-08-05
August, 2019 FDA 483 ITxM Clinical Services - Form 483, 2019-08-01

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more